NDC 0781-3530 – Cyclophosphamide
Cyclophosphamide 2000 mg/20mL · Injection, Solution, Concentrate · Intravenous
Product NDC0781-3530
Product details
- Brand name
- Cyclophosphamide
- Generic name
- Cyclophosphamide
- Labeler
- Sandoz Inc
- Dosage form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Marketing category
- NDA · NDA217150
- Marketed since
- April 8, 2024
- Listing expires
- December 31, 2026
Active ingredients
- Cyclophosphamide 2000 mg/20mL
Uses, dosage, side effects and warnings for Cyclophosphamide →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0781-3530-10 | 1 VIAL, MULTI-DOSE in 1 CARTON (0781-3530-10) / 20 mL in 1 VIAL, MULTI-DOSE (0781-3530-80) | Apr 8, 2024 |
Recalls mentioning this NDC
- D-0651-2025 Sep 24, 2025 · Class II
cGMP deviations: Temperature excursion during transportation.
Other Cyclophosphamide products
- 0781-3528 Cyclophosphamide 500 mg/5mL · Injection, Solution, Concentrate · Sandoz Inc
- 0781-3529 Cyclophosphamide 1000 mg/10mL · Injection, Solution, Concentrate · Sandoz Inc
- 62332-618 Cyclophosphamide 25 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-619 Cyclophosphamide 50 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-618 Cyclophosphamide 25 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 46708-619 Cyclophosphamide 50 mg/1 · Capsule · Alembic Pharmaceuticals Limited
- 70121-1240 Cyclophosphamide 2 g/100mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC
- 70121-1238 Cyclophosphamide 500 mg/25mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC
- 70121-1239 Cyclophosphamide 1 g/50mL · Injection, Powder, For Solution · Amneal Pharmaceuticals LLC
- 83634-206 Cyclophosphamide 1 g/50mL · Injection, Powder, For Solution · Avenacy, LLC
- 83634-207 Cyclophosphamide 2 g/100mL · Injection, Powder, For Solution · Avenacy, LLC
- 83634-205 Cyclophosphamide 500 mg/25mL · Injection, Powder, For Solution · Avenacy, LLC